Labeled for this condition
Medicines for anemia
25 medicines have an FDA label indicated for anemia; 14 are listed from generic labelers and 2 have a presentation in shortage now (FDA files, October 8, 2026).
Which medicines are labeled for anemia?
Each label names the condition in its indications; the record shows the label's words. A list of labeled medicines is not a treatment plan.
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Prednisone | none listed | 45 labelers | $0.0643 per tablet 20 mg tablet | No | No current entry | 10 |
| Triamcinolone | Kenalog, Triesence, Nasacort | 73 labelers | $0.0452 per gram 0.1% cream | No | Listed; available | 27 |
| Dexamethasone | Ozurdex, Maxidex, Hemady | 60 labelers | $0.193 per tablet 4 mg tablet | No | In shortage | 8 |
| Methylprednisolone | Solu-Medrol, Depo-Medrol, Medrol | 35 labelers | $0.121 per tablet 4 mg tablet | No | In shortage | 46 |
| Lenalidomide | Revlimid | 18 labelers | n/a | Yes | No current entry | 0 |
| Betamethasone | Celestone, Sernivo, Diprolene | 28 labelers | $0.418 per gram 0.05% cream | No | No current entry | 13 |
| Eltrombopag | Promacta, Alvaiz | 13 labelers | $25.85 per tablet 50 mg tablet | Yes | No current entry | 1 |
| Prednisolone | Orapred, Pred | 25 labelers | $4.72 per mL 1% eye drop | No | No current entry | 9 |
| Cyanocobalamin | Nascobal | 23 labelers | $1.47 per mL 1,000 mcg/mL vial | No | No current entry | 7 |
| Leuprolide | Lupron, Eligard, Camcevi | 12 labelers | $197.61 per unit 2wk 14 mg/2.8 mL kt | No | No current entry | 6 |
| Epoetin | Retacrit, Procrit, Epogen | none listed | $32.27 per mL 2,000 units/mL vial | Yes | No current entry | 2 |
| Iron sucrose | Venofer | 3 labelers | n/a | No | A presentation being discontinued | 4 |
| Darbepoetin alfa | Aranesp | none listed | $446.58 per mL 25 mcg/0.42 mL syring | Yes | No current entry | 0 |
| Methoxy polyethylene glycol-epoetin beta | Mircera | none listed | n/a | Yes | No current entry | 0 |
| Mitapivat | Pyrukynd, Aqvesme | none listed | n/a | No | No current entry | 0 |
| Daprodustat | Jesduvroq | none listed | n/a | Yes | No current entry | 0 |
| Ferumoxytol | Ferabright, Feraheme | 1 labeler | n/a | Yes | No current entry | 0 |
| Sodium ferric gluconate complex | Ferrlecit | 1 labeler | n/a | No | No current entry | 1 |
| Ferric derisomaltose | Monoferric | none listed | n/a | No | No current entry | 0 |
| Imetelstat | Rytelo | none listed | n/a | No | No current entry | 0 |
| Vadadustat | Vafseo | none listed | n/a | Yes | No current entry | 0 |
| Luspatercept | Reblozyl | none listed | n/a | No | No current entry | 0 |
| Nipocalimab | Imaavy | none listed | n/a | No | No current entry | 0 |
| Tetraferric tricitrate decahydrate | Auryxia | none listed | $6.28 per tablet 210 mg tablet | No | No current entry | 0 |
| Ferric citrate | none listed | 1 labeler | n/a | No | No current entry | 4 |
Source: FDA drug labels (indications) via openFDA; NDC Directory; CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price